Disease burden of hematological malignancies worldwide, in China and in the United States based on the GLOBOCAN 2022 and Global Burden of Disease 2021 data
This study highlights the serious burden of hematological malignancies worldwide, in China, and in the US, emphasizing the urgency for effective prevention and treatment strategies.
Authors
- Minghao Lin (ORCID: https://orcid.org/0009-0003-9090-7959)
- Xiaoyin Huang (ORCID: https://orcid.org/0009-0008-4760-7164)
- Wei Sun
Institutions
- Peking University (CN)
- Peking University People's Hospital (CN)
- Center for Life Sciences (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1097/cm9.0000000000003969
- Primary Topic
- Multiple and Secondary Primary Cancers
- Type
- article
- Field-Weighted Citation Impact
- 0.00